| scholarly article | Q13442814 |
| P50 | author | Alassane Dicko | Q72250716 |
| Roly Gosling | Q90760327 | ||
| Harouna M Soumare | Q102203891 | ||
| Jimee Hwang | Q102205364 | ||
| Joelle Brown | Q114369292 | ||
| Kjerstin H W Lanke | Q114401434 | ||
| Halimatou Diawara | Q114402289 | ||
| Sékou Traoré | Q114755887 | ||
| Ingrid Chen | Q117278017 | ||
| Almahamoudou Mahamar | Q117278018 | ||
| Koualy Sanogo | Q117278019 | ||
| Teun Bousema | Q44168464 | ||
| Chris J Drakeley | Q56774786 | ||
| Vinay Srinivasan | Q57905260 | ||
| John Bradley | Q64605853 | ||
| P2093 | author name string | Olaf Müller | |
| Charles McCulloch | |||
| Michelle E Roh | |||
| Will J R Stone | |||
| Sekouba Keita | |||
| Daouda T Kone | |||
| Djibrilla Issiaka | |||
| Kalifa Diarra | |||
| P2860 | cites work | Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial | Q21562479 |
| The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015 | Q28267425 | ||
| Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate | Q28469316 | ||
| Safety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso | Q28472182 | ||
| A randomised trial to compare the safety, tolerability and efficacy of three drug combinations for intermittent preventive treatment in children | Q28474568 | ||
| Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies | Q28475084 | ||
| Single Low Dose Primaquine (0.25 mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient Subjects | Q28550990 | ||
| Effectiveness of Seasonal Malaria Chemoprevention in Children under Ten Years of Age in Senegal: A Stepped-Wedge Cluster-Randomised Trial | Q28553641 | ||
| Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children | Q33507089 | ||
| Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs | Q33898575 | ||
| The effect of primaquine on gametocyte development and clearance in the treatment of uncomplicated falciparum malaria with dihydroartemisinin-piperaquine in South sumatra, Western indonesia: an open-label, randomized, controlled trial | Q34486508 | ||
| Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria | Q34968407 | ||
| Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination | Q35224221 | ||
| Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue | Q35571456 | ||
| Male and female Plasmodium falciparum mature gametocytes show different responses to antimalarial drugs | Q36969808 | ||
| Short-term Impact of Mass Drug Administration With Dihydroartemisinin Plus Piperaquine on Malaria in Southern Province Zambia: A Cluster-Randomized Controlled Trial | Q37480626 | ||
| Impact of intermittent preventive treatment with dihydroartemisinin-piperaquine on malaria in Ugandan schoolchildren: a randomized, placebo-controlled trial | Q37726083 | ||
| Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2 trial | Q38904423 | ||
| Efficacy and safety of triple combination therapy with artesunate-amodiaquine-methylene blue for falciparum malaria in children: a randomized controlled trial in Burkina Faso | Q38954634 | ||
| Modelling the benefits of long-acting or transmission-blocking drugs for reducing Plasmodium falciparum transmission by case management or by mass treatment | Q40081071 | ||
| Malaria Infection and Gametocyte Carriage Rates in Preparation for Transmission Blocking Vaccine Trials in Bancoumana, Mali | Q40118476 | ||
| Stage-specific gametocytocidal effect in vitro of the antimalaria drug qinghaosu on Plasmodium falciparum | Q41944750 | ||
| Artemisinin resistance on the Thai-Cambodian border | Q43255541 | ||
| Haemolysis risk in methylene blue treatment of G6PD-sufficient and G6PD-deficient West-African children with uncomplicated falciparum malaria: a synopsis of four RCTs | Q43929062 | ||
| Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum | Q44167789 | ||
| A Molecular Assay to Quantify Male and Female Plasmodium falciparum Gametocytes: Results From 2 Randomized Controlled Trials Using Primaquine for Gametocyte Clearance | Q44168409 | ||
| Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: a randomized trial | Q44168825 | ||
| Safety of Single-Dose Primaquine in G6PD-Deficient and G6PD-Normal Males in Mali Without Malaria: An Open-Label, Phase 1, Dose-Adjustment Trial | Q48022321 | ||
| P433 | issue | 6 | |
| P921 | main subject | Mali | Q912 |
| Plasmodium falciparum | Q311383 | ||
| phase II clinical trial | Q42824440 | ||
| P304 | page(s) | 627-639 | |
| P577 | publication date | 2018-02-06 | |
| P1433 | published in | Lancet Infectious Diseases | Q15724248 |
| P1476 | title | Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial | |
| P478 | volume | 18 |
| Q59801146 | A multiplex assay for the sensitive detection and quantification of male and female Plasmodium falciparum gametocytes |
| Q56347967 | An inexpensive open source 3D-printed membrane feeder for human malaria transmission studies |
| Q64104023 | Biology of Plasmodium falciparum gametocyte sex ratio and implications in malaria parasite transmission |
| Q92429984 | CYP2D6 Polymorphisms and the Safety and Gametocytocidal Activity of Single-Dose Primaquine for Plasmodium falciparum |
| Q50107879 | Drugs that reduce transmission of falciparum malaria |
| Q52565814 | Efficacy and safety of methylene blue in the treatment of malaria: a systematic review. |
| Q62738091 | Gametocyte Sex Ratio: The Key to Understanding Plasmodium falciparum Transmission? |
| Q89433268 | Gametocytocidal drugs: taking the population perspective |
| Q99637357 | Health-related publications on people living in fragile states in the alert zone: a bibliometric analysis |
| Q56993529 | Identification of Antifungal Targets Based on Computer Modeling |
| Q92001627 | Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites |
| Q64928897 | Inhibiting the NLRP3 Inflammasome With Methylene Blue as Treatment Adjunct in Myelodysplasia. |
| Q85417673 | Male-Specific Protein Disulphide Isomerase Function is Essential for Plasmodium Transmission and a Vulnerable Target for Intervention. |
| Q55491440 | Plasmodium falciparum gametocyte dynamics after pyronaridine-artesunate or artemether-lumefantrine treatment. |
| Q90629034 | Safety and efficacy of artesunate-amodiaquine combined with either methylene blue or primaquine in children with falciparum malaria in Burkina Faso: A randomized controlled trial |
| Q90369639 | Significant efficacy of single low dose primaquine compared to stand alone artemisinin combination therapy in reducing gametocyte carriage in Cambodian patients with uncomplicated multidrug resistant Plasmodium falciparum malaria |
Search more.